Skip to main content
. 2017 Aug 9;166(2):527–539. doi: 10.1007/s10549-017-4427-x

Fig. 4.

Fig. 4

FLT-PET Images, top panels a and b show patient 009 an irusostat responder, SUVmax decreased from 3.92 to 2.98 and Ki also decreased from 7.2 to 3.1, the bottom panels (c, d) show a non-responder, SUVmax increased from 3.69 to 4.59 and Ki was not changed significantly (11.2 to 10.3)